biologicals

biologicals

美 [ˌbaɪəˈlɑdʒɪk(ə)l] 　英 [ˌbaɪəˈlɒdʒɪk(ə)l]

• adj.生物学(上)的
• n.【药】生物制品
• 网络生物制剂；生物材料；生物制剂生物制品

词形变化

同义词

英汉解释

英英解释

例句

Anti-infectious agents like quinolones, macrolides, TCM with anti-infectious effect and biologicals & biochemicals, vitamins had grown.

喹诺酮类、大环内酯类、抗感染中成药类抗感染药物以及生物制品与生化药物、维生素类药物均有增长；

Members are appointed by the Director of the WHO Department of Immunization, Vaccines and Biologicals (IVB).

委员由世卫组织免疫、疫苗和生物制品司（IVB）司长委任。

By controlling the relative humidity level in a home, the growth of some sources of biologicals can be minimized.

通过控制房间相对湿度，一些生物污染源的增长就相对降低。

biologicals methods: outputting the nitrogen and phosphorus with biological mass and controlling the algae with biological means.

生物方法：用生物量输出氮磷与用生物方法对小型浮游藻类进行控制。

In severe disease with insufficient treatment response, the new biologicals are indicated before marked joint damages occur.

在治疗反应不足的严重的疾病，新的生物制剂有显着的联合损失表示之前发生。

It has provided useful data for clintcle using biologicals to treat some diseases and lack in. . .

这为临床合理使用生物制剂治疗某些疾病及微量元素缺乏症提供了有用数据。

Adopting the routine allergy tests for detecting the allergy of biologicals.

采用生物制品过敏试验常规检测方法。

"I am thrilled, " says Joe Cohen, who leads the malaria vaccine project at GSK Biologicals.

“我很激动，”葛兰素史克生物技术公司主持了这个疟疾疫苗项目的乔·科恩说。

Chen X Y. 1982. Preparation of fatal bovine serum in tissue culture[J]. International Journal of Biologicals, (1): 37.

陈秀英。1982。用于组织培养的胎牛血清的制备[J]。国际生物制品学杂志，（1）：37。

Another trend is that there are more regional deals being done, and more deals done on biologicals.

另一个趋势是区域性和生物相关性的交易在增多。

serums, vaccines and hormone products may now be referred to as biologicals

血清、疫苗和内泌素制品，现在可称为生物制剂

Ensure proper preparation, packaging, distribution and storage of vaccines, serums, biologicals and other drugs and pharmaceuticals

确保适当的准备，包装，分发和储存疫苗，血清，生物制剂及其他药物和药品

Current status and future directions in our Chinese animal biologicals

我国动物生物制品的研究状况及发展方向

Analyses pros and cons of management mode of our country preventative biologicals supply step by step at present

目前我国预防性生物制品逐级供应管理模式的利弊分析